Kobayashi Y, Fujii K, Hiki Y, Tateno S, Kurokawa A, Kamiyama M
Department of Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Nephron. 1988;48(1):12-7. doi: 10.1159/000184861.
29 patients with IgA nephropathy whose proteinuria persisted at a level of 2.0 g/day or more and who received prednisolone treatment for 1-3 years were retrospectively evaluated on their clinical courses. 13 of 14 patients with renal dysfunction of less than 70 ml/min in initial creatinine clearance (Ccr) values subsequently entered a progressive course during a follow-up period of 47 months, leading to end-stage renal failure in 8 cases. On the other hand, only 1 of the other 15 patients with preserved renal function of 70 ml/min or more ended up with end-stage renal failure during a follow-up period of 74 months, although 7 underwent a progressive course. Three patients in the latter group experienced a prominent reduction in proteinuria to less than 1.0 g/day and maintained renal function. Meanwhile, the steroid group of moderate proteinuric patients with a creatinine clearance greater than 70 ml/min had a benign course, while the nonsteroid group had an unfavorable one. These results suggest that steroid therapy in IgA nephropathy may be able to stabilize a progressive course, especially in the early stage of the disease, although, because they come from an uncontrolled study, a definite conclusion cannot be drawn.
对29例IgA肾病患者进行回顾性临床病程评估,这些患者蛋白尿持续水平在2.0g/天及以上,且接受泼尼松龙治疗1 - 3年。初始肌酐清除率(Ccr)低于70ml/min的14例肾功能不全患者中,有13例在47个月的随访期内病情进展,其中8例发展为终末期肾衰竭。另一方面,在74个月的随访期内,初始Ccr≥70ml/min的另外15例肾功能正常患者中,只有1例发展为终末期肾衰竭,尽管有7例病情进展。后一组中有3例患者蛋白尿显著减少至1.0g/天以下并维持了肾功能。同时,肌酐清除率大于70ml/min的中度蛋白尿患者的类固醇治疗组病程良好,而非类固醇治疗组则预后不佳。这些结果表明,IgA肾病的类固醇治疗可能能够稳定病情进展过程,尤其是在疾病早期,不过,由于本研究为非对照研究,无法得出确切结论。